Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome 12 December 2025
Acadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview 05 November 2025
